ABBV settles US Humira patent with MYL—7/31/23 launch date for MYL’s biosimilar (6mo after AMGN’s launch date and 1mo after Samsung’s launch date): https://finance.yahoo.com/news/abbvie-announces-humira-adalimumab-patent-120500305.html The ABBV-MYL deal also settles Humira litigation between the companies in unspecified ex-US/ex-EU countries. Please see #msg-134976468 and #msg-139804103 for background.